nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—ABCB1—ovarian cancer	0.224	1	CbGaD
Nicardipine—ABCB1—Topotecan—ovarian cancer	0.0358	0.118	CbGbCtD
Nicardipine—CYP3A5—Paclitaxel—ovarian cancer	0.0272	0.0894	CbGbCtD
Nicardipine—CYP2C8—Paclitaxel—ovarian cancer	0.0262	0.086	CbGbCtD
Nicardipine—ABCB1—Vinorelbine—ovarian cancer	0.0252	0.0829	CbGbCtD
Nicardipine—CYP2D6—Vinorelbine—ovarian cancer	0.0238	0.0781	CbGbCtD
Nicardipine—CYP3A4—Topotecan—ovarian cancer	0.0215	0.0705	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—ovarian cancer	0.0197	0.0647	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—ovarian cancer	0.0186	0.0612	CbGbCtD
Nicardipine—CYP2C9—Paclitaxel—ovarian cancer	0.0183	0.06	CbGbCtD
Nicardipine—ABCB1—Paclitaxel—ovarian cancer	0.0177	0.0582	CbGbCtD
Nicardipine—CYP3A4—Vinorelbine—ovarian cancer	0.0151	0.0496	CbGbCtD
Nicardipine—ABCB1—Docetaxel—ovarian cancer	0.0128	0.0421	CbGbCtD
Nicardipine—CYP3A4—Paclitaxel—ovarian cancer	0.0106	0.0349	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—ovarian cancer	0.00956	0.0314	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—ovarian cancer	0.009	0.0296	CbGbCtD
Nicardipine—CHRM3—muscle of abdomen—ovarian cancer	0.00839	0.0773	CbGeAlD
Nicardipine—CYP3A4—Docetaxel—ovarian cancer	0.00768	0.0252	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—ovarian cancer	0.00573	0.0188	CbGbCtD
Nicardipine—CALM2—oviduct—ovarian cancer	0.0039	0.0359	CbGeAlD
Nicardipine—PDE1B—gonad—ovarian cancer	0.00248	0.0229	CbGeAlD
Nicardipine—PDE1A—uterine cervix—ovarian cancer	0.00248	0.0228	CbGeAlD
Nicardipine—PDE1B—female reproductive system—ovarian cancer	0.00222	0.0204	CbGeAlD
Nicardipine—PDE1A—gonad—ovarian cancer	0.00208	0.0192	CbGeAlD
Nicardipine—PDE1A—uterus—ovarian cancer	0.00207	0.019	CbGeAlD
Nicardipine—CACNA1C—myometrium—ovarian cancer	0.00189	0.0174	CbGeAlD
Nicardipine—PDE1A—female reproductive system—ovarian cancer	0.00186	0.0171	CbGeAlD
Nicardipine—PDE1B—testis—ovarian cancer	0.00179	0.0165	CbGeAlD
Nicardipine—CHRM5—epithelium—ovarian cancer	0.00179	0.0165	CbGeAlD
Nicardipine—PDE1A—female gonad—ovarian cancer	0.00169	0.0156	CbGeAlD
Nicardipine—ADRA1D—epithelium—ovarian cancer	0.0016	0.0147	CbGeAlD
Nicardipine—CACNA1D—uterine cervix—ovarian cancer	0.0016	0.0147	CbGeAlD
Nicardipine—CALM3—myometrium—ovarian cancer	0.00159	0.0146	CbGeAlD
Nicardipine—PDE1A—testis—ovarian cancer	0.0015	0.0138	CbGeAlD
Nicardipine—CACNA1C—decidua—ovarian cancer	0.0014	0.0129	CbGeAlD
Nicardipine—CHRM4—testis—ovarian cancer	0.00137	0.0126	CbGeAlD
Nicardipine—PDE1B—lymph node—ovarian cancer	0.0013	0.0119	CbGeAlD
Nicardipine—CALM2—myometrium—ovarian cancer	0.00125	0.0115	CbGeAlD
Nicardipine—CALM1—myometrium—ovarian cancer	0.00124	0.0114	CbGeAlD
Nicardipine—CACNB2—vagina—ovarian cancer	0.00124	0.0114	CbGeAlD
Nicardipine—CALM3—uterine cervix—ovarian cancer	0.00123	0.0114	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—ovarian cancer	0.00121	0.0112	CbGeAlD
Nicardipine—CALM2—embryo—ovarian cancer	0.0012	0.011	CbGeAlD
Nicardipine—CALM1—embryo—ovarian cancer	0.00119	0.011	CbGeAlD
Nicardipine—ADRA1D—female reproductive system—ovarian cancer	0.00119	0.0109	CbGeAlD
Nicardipine—CALM3—decidua—ovarian cancer	0.00118	0.0108	CbGeAlD
Nicardipine—CACNA2D1—female gonad—ovarian cancer	0.00117	0.0108	CbGeAlD
Nicardipine—CACNA2D1—vagina—ovarian cancer	0.00116	0.0107	CbGeAlD
Nicardipine—CALM3—endometrium—ovarian cancer	0.00112	0.0103	CbGeAlD
Nicardipine—CACNB2—testis—ovarian cancer	0.0011	0.0102	CbGeAlD
Nicardipine—CACNA1C—female reproductive system—ovarian cancer	0.0011	0.0102	CbGeAlD
Nicardipine—PDE1A—lymph node—ovarian cancer	0.00109	0.01	CbGeAlD
Nicardipine—CACNA2D1—testis—ovarian cancer	0.00104	0.00956	CbGeAlD
Nicardipine—CALM3—uterus—ovarian cancer	0.00103	0.00948	CbGeAlD
Nicardipine—CACNA1C—vagina—ovarian cancer	0.000999	0.0092	CbGeAlD
Nicardipine—CALM2—epithelium—ovarian cancer	0.000978	0.00901	CbGeAlD
Nicardipine—CALM1—epithelium—ovarian cancer	0.000974	0.00897	CbGeAlD
Nicardipine—CALM2—uterine cervix—ovarian cancer	0.00097	0.00893	CbGeAlD
Nicardipine—CACNA1D—testis—ovarian cancer	0.000966	0.00889	CbGeAlD
Nicardipine—CALM1—uterine cervix—ovarian cancer	0.000965	0.00889	CbGeAlD
Nicardipine—CALM2—decidua—ovarian cancer	0.000924	0.00851	CbGeAlD
Nicardipine—CALM1—decidua—ovarian cancer	0.00092	0.00847	CbGeAlD
Nicardipine—ADRA1A—epithelium—ovarian cancer	0.000917	0.00845	CbGeAlD
Nicardipine—CACNA1C—testis—ovarian cancer	0.000892	0.00821	CbGeAlD
Nicardipine—CALM2—endometrium—ovarian cancer	0.000877	0.00808	CbGeAlD
Nicardipine—CALM3—bone marrow—ovarian cancer	0.000874	0.00805	CbGeAlD
Nicardipine—CALM1—endometrium—ovarian cancer	0.000873	0.00804	CbGeAlD
Nicardipine—CALM3—female gonad—ovarian cancer	0.000842	0.00775	CbGeAlD
Nicardipine—CALM3—vagina—ovarian cancer	0.000837	0.00771	CbGeAlD
Nicardipine—CHRM1—female reproductive system—ovarian cancer	0.00083	0.00764	CbGeAlD
Nicardipine—CALM2—gonad—ovarian cancer	0.000814	0.00749	CbGeAlD
Nicardipine—CALM1—gonad—ovarian cancer	0.00081	0.00746	CbGeAlD
Nicardipine—CALM2—uterus—ovarian cancer	0.000808	0.00744	CbGeAlD
Nicardipine—CALM1—uterus—ovarian cancer	0.000805	0.00741	CbGeAlD
Nicardipine—CACNB2—lymph node—ovarian cancer	0.000801	0.00738	CbGeAlD
Nicardipine—CACNA2D1—lymph node—ovarian cancer	0.000752	0.00693	CbGeAlD
Nicardipine—CALM3—testis—ovarian cancer	0.000747	0.00688	CbGeAlD
Nicardipine—CHRM3—female reproductive system—ovarian cancer	0.000742	0.00684	CbGeAlD
Nicardipine—CYP2C8—endometrium—ovarian cancer	0.000727	0.0067	CbGeAlD
Nicardipine—CALM2—female reproductive system—ovarian cancer	0.000727	0.00669	CbGeAlD
Nicardipine—CYP3A5—uterine cervix—ovarian cancer	0.000725	0.00668	CbGeAlD
Nicardipine—CALM1—female reproductive system—ovarian cancer	0.000723	0.00666	CbGeAlD
Nicardipine—CACNA1D—lymph node—ovarian cancer	0.0007	0.00645	CbGeAlD
Nicardipine—CALM2—bone marrow—ovarian cancer	0.000686	0.00632	CbGeAlD
Nicardipine—CALM1—bone marrow—ovarian cancer	0.000683	0.00629	CbGeAlD
Nicardipine—CHRM3—female gonad—ovarian cancer	0.000675	0.00622	CbGeAlD
Nicardipine—CALM2—female gonad—ovarian cancer	0.000661	0.00609	CbGeAlD
Nicardipine—CALM1—female gonad—ovarian cancer	0.000658	0.00606	CbGeAlD
Nicardipine—CALM2—vagina—ovarian cancer	0.000657	0.00605	CbGeAlD
Nicardipine—CALM1—vagina—ovarian cancer	0.000654	0.00602	CbGeAlD
Nicardipine—CACNA1C—lymph node—ovarian cancer	0.000646	0.00595	CbGeAlD
Nicardipine—CYP2C19—vagina—ovarian cancer	0.000624	0.00575	CbGeAlD
Nicardipine—CYP2B6—gonad—ovarian cancer	0.000605	0.00557	CbGeAlD
Nicardipine—CYP2C8—female reproductive system—ovarian cancer	0.000602	0.00555	CbGeAlD
Nicardipine—CHRM3—testis—ovarian cancer	0.000599	0.00552	CbGeAlD
Nicardipine—CALM2—testis—ovarian cancer	0.000586	0.0054	CbGeAlD
Nicardipine—CALM1—testis—ovarian cancer	0.000584	0.00538	CbGeAlD
Nicardipine—CYP2C8—vagina—ovarian cancer	0.000545	0.00502	CbGeAlD
Nicardipine—CALM3—lymph node—ovarian cancer	0.000541	0.00499	CbGeAlD
Nicardipine—CYP2B6—female reproductive system—ovarian cancer	0.00054	0.00498	CbGeAlD
Nicardipine—CYP2C9—female reproductive system—ovarian cancer	0.000535	0.00493	CbGeAlD
Nicardipine—CYP2E1—female reproductive system—ovarian cancer	0.000507	0.00467	CbGeAlD
Nicardipine—ABCB1—myometrium—ovarian cancer	0.000495	0.00456	CbGeAlD
Nicardipine—CYP3A5—female gonad—ovarian cancer	0.000495	0.00455	CbGeAlD
Nicardipine—CYP3A5—vagina—ovarian cancer	0.000492	0.00453	CbGeAlD
Nicardipine—CYP2B6—vagina—ovarian cancer	0.000489	0.0045	CbGeAlD
Nicardipine—CYP2C8—testis—ovarian cancer	0.000486	0.00448	CbGeAlD
Nicardipine—ABCB1—embryo—ovarian cancer	0.000476	0.00439	CbGeAlD
Nicardipine—CYP2B6—testis—ovarian cancer	0.000436	0.00402	CbGeAlD
Nicardipine—CALM2—lymph node—ovarian cancer	0.000425	0.00391	CbGeAlD
Nicardipine—CALM1—lymph node—ovarian cancer	0.000423	0.0039	CbGeAlD
Nicardipine—CYP2E1—testis—ovarian cancer	0.000409	0.00377	CbGeAlD
Nicardipine—CYP3A4—female reproductive system—ovarian cancer	0.000408	0.00376	CbGeAlD
Nicardipine—CYP2D6—female reproductive system—ovarian cancer	0.000401	0.0037	CbGeAlD
Nicardipine—Hypertonia—Doxorubicin—ovarian cancer	0.000392	0.00228	CcSEcCtD
Nicardipine—Abnormal vision—Doxorubicin—ovarian cancer	0.00039	0.00227	CcSEcCtD
Nicardipine—Conjunctivitis—Docetaxel—ovarian cancer	0.000389	0.00227	CcSEcCtD
Nicardipine—ABCB1—epithelium—ovarian cancer	0.000389	0.00358	CbGeAlD
Nicardipine—Hypersensitivity—Topotecan—ovarian cancer	0.000386	0.00225	CcSEcCtD
Nicardipine—ABCB1—uterine cervix—ovarian cancer	0.000385	0.00355	CbGeAlD
Nicardipine—Constipation—Vinorelbine—ovarian cancer	0.000383	0.00223	CcSEcCtD
Nicardipine—Pain—Vinorelbine—ovarian cancer	0.000383	0.00223	CcSEcCtD
Nicardipine—Hypersensitivity—Melphalan—ovarian cancer	0.000378	0.0022	CcSEcCtD
Nicardipine—Asthenia—Topotecan—ovarian cancer	0.000376	0.00219	CcSEcCtD
Nicardipine—Hot flush—Epirubicin—ovarian cancer	0.000375	0.00218	CcSEcCtD
Nicardipine—Vomiting—Chlorambucil—ovarian cancer	0.000374	0.00218	CcSEcCtD
Nicardipine—Menopausal symptoms—Epirubicin—ovarian cancer	0.000372	0.00216	CcSEcCtD
Nicardipine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000369	0.00215	CcSEcCtD
Nicardipine—Asthenia—Melphalan—ovarian cancer	0.000368	0.00214	CcSEcCtD
Nicardipine—ABCB1—decidua—ovarian cancer	0.000367	0.00338	CbGeAlD
Nicardipine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000366	0.00213	CcSEcCtD
Nicardipine—CYP2D6—female gonad—ovarian cancer	0.000365	0.00336	CbGeAlD
Nicardipine—Tension—Paclitaxel—ovarian cancer	0.000362	0.00211	CcSEcCtD
Nicardipine—Rhinitis—Docetaxel—ovarian cancer	0.000361	0.0021	CcSEcCtD
Nicardipine—Nervousness—Paclitaxel—ovarian cancer	0.000359	0.00209	CcSEcCtD
Nicardipine—Diarrhoea—Topotecan—ovarian cancer	0.000358	0.00209	CcSEcCtD
Nicardipine—Hypoaesthesia—Docetaxel—ovarian cancer	0.000358	0.00208	CcSEcCtD
Nicardipine—Body temperature increased—Vinorelbine—ovarian cancer	0.000354	0.00206	CcSEcCtD
Nicardipine—Abdominal pain—Vinorelbine—ovarian cancer	0.000354	0.00206	CcSEcCtD
Nicardipine—Oedema peripheral—Docetaxel—ovarian cancer	0.000354	0.00206	CcSEcCtD
Nicardipine—Diarrhoea—Melphalan—ovarian cancer	0.000351	0.00204	CcSEcCtD
Nicardipine—Nausea—Chlorambucil—ovarian cancer	0.00035	0.00204	CcSEcCtD
Nicardipine—ABCB1—endometrium—ovarian cancer	0.000349	0.00321	CbGeAlD
Nicardipine—Vision blurred—Paclitaxel—ovarian cancer	0.000348	0.00203	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—ovarian cancer	0.000347	0.00202	CcSEcCtD
Nicardipine—Visual impairment—Docetaxel—ovarian cancer	0.000347	0.00202	CcSEcCtD
Nicardipine—Dizziness—Topotecan—ovarian cancer	0.000346	0.00202	CcSEcCtD
Nicardipine—Tremor—Paclitaxel—ovarian cancer	0.000346	0.00202	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000344	0.002	CcSEcCtD
Nicardipine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000343	0.002	CcSEcCtD
Nicardipine—Agitation—Paclitaxel—ovarian cancer	0.000339	0.00198	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—ovarian cancer	0.000338	0.00197	CcSEcCtD
Nicardipine—Flushing—Docetaxel—ovarian cancer	0.000334	0.00194	CcSEcCtD
Nicardipine—Vomiting—Topotecan—ovarian cancer	0.000333	0.00194	CcSEcCtD
Nicardipine—Malaise—Paclitaxel—ovarian cancer	0.000333	0.00194	CcSEcCtD
Nicardipine—Vertigo—Paclitaxel—ovarian cancer	0.000332	0.00193	CcSEcCtD
Nicardipine—Syncope—Paclitaxel—ovarian cancer	0.000331	0.00193	CcSEcCtD
Nicardipine—Rash—Topotecan—ovarian cancer	0.00033	0.00192	CcSEcCtD
Nicardipine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00033	0.00192	CcSEcCtD
Nicardipine—Dermatitis—Topotecan—ovarian cancer	0.00033	0.00192	CcSEcCtD
Nicardipine—Headache—Topotecan—ovarian cancer	0.000328	0.00191	CcSEcCtD
Nicardipine—Palpitations—Paclitaxel—ovarian cancer	0.000326	0.0019	CcSEcCtD
Nicardipine—Vomiting—Melphalan—ovarian cancer	0.000326	0.0019	CcSEcCtD
Nicardipine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000325	0.00189	CcSEcCtD
Nicardipine—CYP2D6—testis—ovarian cancer	0.000324	0.00298	CbGeAlD
Nicardipine—Rash—Melphalan—ovarian cancer	0.000323	0.00188	CcSEcCtD
Nicardipine—ABCB1—gonad—ovarian cancer	0.000323	0.00298	CbGeAlD
Nicardipine—Dermatitis—Melphalan—ovarian cancer	0.000323	0.00188	CcSEcCtD
Nicardipine—Asthenia—Vinorelbine—ovarian cancer	0.000322	0.00187	CcSEcCtD
Nicardipine—ABCB1—uterus—ovarian cancer	0.000321	0.00296	CbGeAlD
Nicardipine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00032	0.00187	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—ovarian cancer	0.000319	0.00186	CcSEcCtD
Nicardipine—Hypertension—Paclitaxel—ovarian cancer	0.000319	0.00186	CcSEcCtD
Nicardipine—Arthralgia—Paclitaxel—ovarian cancer	0.000314	0.00183	CcSEcCtD
Nicardipine—Chest pain—Paclitaxel—ovarian cancer	0.000314	0.00183	CcSEcCtD
Nicardipine—Myalgia—Paclitaxel—ovarian cancer	0.000314	0.00183	CcSEcCtD
Nicardipine—Anxiety—Paclitaxel—ovarian cancer	0.000313	0.00183	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—ovarian cancer	0.000313	0.00182	CcSEcCtD
Nicardipine—Nausea—Topotecan—ovarian cancer	0.000311	0.00181	CcSEcCtD
Nicardipine—Discomfort—Paclitaxel—ovarian cancer	0.000311	0.00181	CcSEcCtD
Nicardipine—Dry mouth—Paclitaxel—ovarian cancer	0.000307	0.00179	CcSEcCtD
Nicardipine—Diarrhoea—Vinorelbine—ovarian cancer	0.000307	0.00179	CcSEcCtD
Nicardipine—Nausea—Melphalan—ovarian cancer	0.000305	0.00178	CcSEcCtD
Nicardipine—Confusional state—Paclitaxel—ovarian cancer	0.000304	0.00177	CcSEcCtD
Nicardipine—Oedema—Paclitaxel—ovarian cancer	0.000301	0.00176	CcSEcCtD
Nicardipine—Infection—Paclitaxel—ovarian cancer	0.000299	0.00174	CcSEcCtD
Nicardipine—Shock—Paclitaxel—ovarian cancer	0.000297	0.00173	CcSEcCtD
Nicardipine—Dizziness—Vinorelbine—ovarian cancer	0.000296	0.00173	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000296	0.00173	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—ovarian cancer	0.000295	0.00172	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—ovarian cancer	0.000295	0.00172	CcSEcCtD
Nicardipine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000295	0.00172	CcSEcCtD
Nicardipine—Tachycardia—Paclitaxel—ovarian cancer	0.000294	0.00171	CcSEcCtD
Nicardipine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000291	0.0017	CcSEcCtD
Nicardipine—ABCB1—female reproductive system—ovarian cancer	0.000289	0.00266	CbGeAlD
Nicardipine—Vomiting—Vinorelbine—ovarian cancer	0.000285	0.00166	CcSEcCtD
Nicardipine—Rash—Vinorelbine—ovarian cancer	0.000283	0.00165	CcSEcCtD
Nicardipine—Dermatitis—Vinorelbine—ovarian cancer	0.000282	0.00164	CcSEcCtD
Nicardipine—Hypotension—Paclitaxel—ovarian cancer	0.000282	0.00164	CcSEcCtD
Nicardipine—Headache—Vinorelbine—ovarian cancer	0.000281	0.00164	CcSEcCtD
Nicardipine—Syncope—Docetaxel—ovarian cancer	0.000281	0.00164	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—ovarian cancer	0.00028	0.00163	CcSEcCtD
Nicardipine—Palpitations—Docetaxel—ovarian cancer	0.000277	0.00161	CcSEcCtD
Nicardipine—Loss of consciousness—Docetaxel—ovarian cancer	0.000275	0.0016	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000275	0.0016	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—ovarian cancer	0.000273	0.00159	CcSEcCtD
Nicardipine—Insomnia—Paclitaxel—ovarian cancer	0.000273	0.00159	CcSEcCtD
Nicardipine—ABCB1—bone marrow—ovarian cancer	0.000273	0.00251	CbGeAlD
Nicardipine—Paraesthesia—Paclitaxel—ovarian cancer	0.000271	0.00158	CcSEcCtD
Nicardipine—Hypertension—Docetaxel—ovarian cancer	0.00027	0.00157	CcSEcCtD
Nicardipine—Dyspnoea—Paclitaxel—ovarian cancer	0.000269	0.00157	CcSEcCtD
Nicardipine—Somnolence—Paclitaxel—ovarian cancer	0.000268	0.00156	CcSEcCtD
Nicardipine—Chest pain—Docetaxel—ovarian cancer	0.000266	0.00155	CcSEcCtD
Nicardipine—Myalgia—Docetaxel—ovarian cancer	0.000266	0.00155	CcSEcCtD
Nicardipine—Arthralgia—Docetaxel—ovarian cancer	0.000266	0.00155	CcSEcCtD
Nicardipine—Nausea—Vinorelbine—ovarian cancer	0.000266	0.00155	CcSEcCtD
Nicardipine—Dyspepsia—Paclitaxel—ovarian cancer	0.000265	0.00155	CcSEcCtD
Nicardipine—ABCB1—female gonad—ovarian cancer	0.000263	0.00242	CbGeAlD
Nicardipine—Conjunctivitis—Epirubicin—ovarian cancer	0.000263	0.00153	CcSEcCtD
Nicardipine—ABCB1—vagina—ovarian cancer	0.000261	0.00241	CbGeAlD
Nicardipine—Dry mouth—Docetaxel—ovarian cancer	0.000261	0.00152	CcSEcCtD
Nicardipine—Sweating—Epirubicin—ovarian cancer	0.000259	0.00151	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—ovarian cancer	0.000259	0.00151	CcSEcCtD
Nicardipine—Pain—Paclitaxel—ovarian cancer	0.000258	0.0015	CcSEcCtD
Nicardipine—Constipation—Paclitaxel—ovarian cancer	0.000258	0.0015	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—ovarian cancer	0.000258	0.0015	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—ovarian cancer	0.000258	0.0015	CcSEcCtD
Nicardipine—Oedema—Docetaxel—ovarian cancer	0.000255	0.00149	CcSEcCtD
Nicardipine—Infection—Docetaxel—ovarian cancer	0.000254	0.00148	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—ovarian cancer	0.000253	0.00148	CcSEcCtD
Nicardipine—Shock—Docetaxel—ovarian cancer	0.000251	0.00146	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00025	0.00146	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—ovarian cancer	0.000249	0.00145	CcSEcCtD
Nicardipine—Nisoldipine—ABCB1—ovarian cancer	0.000249	0.238	CrCbGaD
Nicardipine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000248	0.00145	CcSEcCtD
Nicardipine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000246	0.00144	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—ovarian cancer	0.000243	0.00142	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000243	0.00142	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000241	0.00141	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—ovarian cancer	0.00024	0.0014	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—ovarian cancer	0.000239	0.00139	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—ovarian cancer	0.000239	0.00139	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—ovarian cancer	0.000238	0.00139	CcSEcCtD
Nicardipine—Abdominal pain—Paclitaxel—ovarian cancer	0.000238	0.00139	CcSEcCtD
Nicardipine—Body temperature increased—Paclitaxel—ovarian cancer	0.000238	0.00139	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—ovarian cancer	0.000235	0.00137	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—ovarian cancer	0.000234	0.00136	CcSEcCtD
Nicardipine—ABCB1—testis—ovarian cancer	0.000233	0.00215	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000233	0.00136	CcSEcCtD
Nicardipine—Nitrendipine—ABCB1—ovarian cancer	0.000233	0.222	CrCbGaD
Nicardipine—Insomnia—Docetaxel—ovarian cancer	0.000231	0.00135	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—ovarian cancer	0.000229	0.00134	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—ovarian cancer	0.000228	0.00133	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—ovarian cancer	0.000227	0.00132	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—ovarian cancer	0.000226	0.00132	CcSEcCtD
Nicardipine—Flushing—Epirubicin—ovarian cancer	0.000225	0.00131	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—ovarian cancer	0.000225	0.00131	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—ovarian cancer	0.000225	0.00131	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000223	0.0013	CcSEcCtD
Nicardipine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000222	0.00129	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000221	0.00129	CcSEcCtD
Nicardipine—Pain—Docetaxel—ovarian cancer	0.000218	0.00127	CcSEcCtD
Nicardipine—Constipation—Docetaxel—ovarian cancer	0.000218	0.00127	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—ovarian cancer	0.000216	0.00126	CcSEcCtD
Nicardipine—Asthenia—Paclitaxel—ovarian cancer	0.000216	0.00126	CcSEcCtD
Nicardipine—Feeling abnormal—Docetaxel—ovarian cancer	0.000211	0.00123	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—ovarian cancer	0.000209	0.00122	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000209	0.00122	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—ovarian cancer	0.000208	0.00121	CcSEcCtD
Nicardipine—Tension—Epirubicin—ovarian cancer	0.000207	0.00121	CcSEcCtD
Nicardipine—Diarrhoea—Paclitaxel—ovarian cancer	0.000206	0.0012	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—ovarian cancer	0.000205	0.00119	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—ovarian cancer	0.000202	0.00118	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—ovarian cancer	0.000202	0.00118	CcSEcCtD
Nicardipine—Amlodipine—ABCB1—ovarian cancer	0.0002	0.191	CrCbGaD
Nicardipine—Dizziness—Paclitaxel—ovarian cancer	0.000199	0.00116	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—ovarian cancer	0.000199	0.00116	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000196	0.00114	CcSEcCtD
Nicardipine—Agitation—Epirubicin—ovarian cancer	0.000194	0.00113	CcSEcCtD
Nicardipine—Tension—Doxorubicin—ovarian cancer	0.000192	0.00112	CcSEcCtD
Nicardipine—Vomiting—Paclitaxel—ovarian cancer	0.000192	0.00112	CcSEcCtD
Nicardipine—Malaise—Epirubicin—ovarian cancer	0.00019	0.00111	CcSEcCtD
Nicardipine—Rash—Paclitaxel—ovarian cancer	0.00019	0.00111	CcSEcCtD
Nicardipine—Dermatitis—Paclitaxel—ovarian cancer	0.00019	0.00111	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—ovarian cancer	0.00019	0.00111	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—ovarian cancer	0.00019	0.00111	CcSEcCtD
Nicardipine—Syncope—Epirubicin—ovarian cancer	0.000189	0.0011	CcSEcCtD
Nicardipine—Headache—Paclitaxel—ovarian cancer	0.000189	0.0011	CcSEcCtD
Nicardipine—Hypersensitivity—Docetaxel—ovarian cancer	0.000188	0.0011	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—ovarian cancer	0.000187	0.00109	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—ovarian cancer	0.000186	0.00108	CcSEcCtD
Nicardipine—Felodipine—ABCB1—ovarian cancer	0.000185	0.177	CrCbGaD
Nicardipine—Vision blurred—Doxorubicin—ovarian cancer	0.000184	0.00107	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—ovarian cancer	0.000183	0.00107	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—ovarian cancer	0.000182	0.00106	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000181	0.00106	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—ovarian cancer	0.00018	0.00105	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—ovarian cancer	0.00018	0.00105	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—ovarian cancer	0.00018	0.00105	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—ovarian cancer	0.00018	0.00105	CcSEcCtD
Nicardipine—Nifedipine—ABCB1—ovarian cancer	0.000179	0.171	CrCbGaD
Nicardipine—Anxiety—Epirubicin—ovarian cancer	0.000179	0.00104	CcSEcCtD
Nicardipine—Nausea—Paclitaxel—ovarian cancer	0.000179	0.00104	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—ovarian cancer	0.000178	0.00103	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—ovarian cancer	0.000176	0.00103	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—ovarian cancer	0.000176	0.00102	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—ovarian cancer	0.000176	0.00102	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—ovarian cancer	0.000175	0.00102	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—ovarian cancer	0.000175	0.00102	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—ovarian cancer	0.000174	0.00101	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—ovarian cancer	0.000173	0.00101	CcSEcCtD
Nicardipine—Oedema—Epirubicin—ovarian cancer	0.000172	0.001	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000172	0.001	CcSEcCtD
Nicardipine—Infection—Epirubicin—ovarian cancer	0.000171	0.000997	CcSEcCtD
Nicardipine—Shock—Epirubicin—ovarian cancer	0.00017	0.000988	CcSEcCtD
Nicardipine—Dizziness—Docetaxel—ovarian cancer	0.000169	0.000984	CcSEcCtD
Nicardipine—ABCB1—lymph node—ovarian cancer	0.000169	0.00156	CbGeAlD
Nicardipine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000169	0.000983	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—ovarian cancer	0.000169	0.000983	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—ovarian cancer	0.000168	0.00098	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000167	0.000971	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—ovarian cancer	0.000166	0.000969	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—ovarian cancer	0.000166	0.000969	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—ovarian cancer	0.000166	0.000969	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—ovarian cancer	0.000166	0.000966	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—ovarian cancer	0.000164	0.000957	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—ovarian cancer	0.000163	0.000948	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—ovarian cancer	0.000162	0.000946	CcSEcCtD
Nicardipine—Rash—Docetaxel—ovarian cancer	0.000161	0.000939	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—ovarian cancer	0.000161	0.000938	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—ovarian cancer	0.000161	0.000938	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—ovarian cancer	0.000161	0.000937	CcSEcCtD
Nicardipine—Headache—Docetaxel—ovarian cancer	0.00016	0.000932	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—ovarian cancer	0.000159	0.000929	CcSEcCtD
Nicardipine—Infection—Doxorubicin—ovarian cancer	0.000158	0.000923	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000157	0.000915	CcSEcCtD
Nicardipine—Shock—Doxorubicin—ovarian cancer	0.000157	0.000914	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000156	0.00091	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—ovarian cancer	0.000156	0.000908	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—ovarian cancer	0.000156	0.000907	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—ovarian cancer	0.000155	0.000902	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000154	0.000898	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—ovarian cancer	0.000154	0.000895	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—ovarian cancer	0.000153	0.000893	CcSEcCtD
Nicardipine—Nausea—Docetaxel—ovarian cancer	0.000152	0.000884	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—ovarian cancer	0.000152	0.000884	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—ovarian cancer	0.000149	0.000868	CcSEcCtD
Nicardipine—Pain—Epirubicin—ovarian cancer	0.000147	0.000859	CcSEcCtD
Nicardipine—Constipation—Epirubicin—ovarian cancer	0.000147	0.000859	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000145	0.000846	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—ovarian cancer	0.000144	0.00084	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—ovarian cancer	0.000143	0.000834	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—ovarian cancer	0.000142	0.000828	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—ovarian cancer	0.000142	0.000827	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—ovarian cancer	0.000142	0.000826	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000141	0.000821	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—ovarian cancer	0.00014	0.000818	CcSEcCtD
Nicardipine—Pain—Doxorubicin—ovarian cancer	0.000136	0.000794	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—ovarian cancer	0.000136	0.000794	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—ovarian cancer	0.000136	0.000794	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—ovarian cancer	0.000136	0.000794	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000131	0.000766	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00013	0.00076	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—ovarian cancer	0.000127	0.00074	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—ovarian cancer	0.000126	0.000734	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—ovarian cancer	0.000126	0.000734	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—ovarian cancer	0.000124	0.00072	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—ovarian cancer	0.000118	0.000687	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000117	0.000684	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—ovarian cancer	0.000114	0.000667	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—ovarian cancer	0.000114	0.000664	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—ovarian cancer	0.00011	0.000638	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—ovarian cancer	0.000109	0.000636	CcSEcCtD
Nicardipine—Rash—Epirubicin—ovarian cancer	0.000109	0.000633	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—ovarian cancer	0.000109	0.000632	CcSEcCtD
Nicardipine—Headache—Epirubicin—ovarian cancer	0.000108	0.000629	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—ovarian cancer	0.000105	0.000614	CcSEcCtD
Nicardipine—Nausea—Epirubicin—ovarian cancer	0.000102	0.000596	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—ovarian cancer	0.000101	0.000591	CcSEcCtD
Nicardipine—Rash—Doxorubicin—ovarian cancer	0.000101	0.000586	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—ovarian cancer	0.0001	0.000585	CcSEcCtD
Nicardipine—Headache—Doxorubicin—ovarian cancer	9.99e-05	0.000582	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—ovarian cancer	9.47e-05	0.000552	CcSEcCtD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	4.81e-06	2.53e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	4.8e-06	2.52e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	4.8e-06	2.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK3—ovarian cancer	4.79e-06	2.51e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK3—ovarian cancer	4.79e-06	2.51e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	4.78e-06	2.51e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	4.75e-06	2.5e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.74e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	4.74e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	4.72e-06	2.48e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—ovarian cancer	4.71e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MAPK1—ovarian cancer	4.71e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—ovarian cancer	4.71e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—ovarian cancer	4.7e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MTOR—ovarian cancer	4.69e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	4.69e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—ovarian cancer	4.69e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—ovarian cancer	4.69e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	4.68e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	4.68e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	4.68e-06	2.46e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	4.67e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TYMS—ovarian cancer	4.66e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—ovarian cancer	4.66e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—ovarian cancer	4.66e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—ovarian cancer	4.65e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—ovarian cancer	4.65e-06	2.45e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	4.6e-06	2.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	4.6e-06	2.42e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	4.6e-06	2.42e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.6e-06	2.42e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	4.58e-06	2.4e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.56e-06	2.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK1—ovarian cancer	4.55e-06	2.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK1—ovarian cancer	4.55e-06	2.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—ovarian cancer	4.55e-06	2.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—ovarian cancer	4.55e-06	2.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	4.54e-06	2.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MTOR—ovarian cancer	4.54e-06	2.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MTOR—ovarian cancer	4.54e-06	2.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	4.54e-06	2.38e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	4.51e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—ovarian cancer	4.5e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—ovarian cancer	4.5e-06	2.36e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	4.48e-06	2.35e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	4.47e-06	2.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—ovarian cancer	4.45e-06	2.34e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—ovarian cancer	4.43e-06	2.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—ovarian cancer	4.42e-06	2.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	4.4e-06	2.31e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	4.39e-06	2.31e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	4.38e-06	2.3e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	4.38e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	4.37e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	4.36e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	4.36e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.36e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	4.35e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	4.33e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	4.33e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	4.33e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	4.33e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	4.33e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	4.32e-06	2.27e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	4.32e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—ovarian cancer	4.32e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—ovarian cancer	4.31e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—ovarian cancer	4.31e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—ovarian cancer	4.3e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—ovarian cancer	4.3e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	4.29e-06	2.25e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—ovarian cancer	4.29e-06	2.25e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—ovarian cancer	4.28e-06	2.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—ovarian cancer	4.28e-06	2.25e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	4.28e-06	2.25e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	4.28e-06	2.25e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	4.27e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	4.26e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	4.26e-06	2.24e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.25e-06	2.23e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	4.23e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—ovarian cancer	4.22e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—ovarian cancer	4.2e-06	2.21e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—ovarian cancer	4.17e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—ovarian cancer	4.17e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—ovarian cancer	4.17e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—ovarian cancer	4.17e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	4.16e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—ovarian cancer	4.15e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	4.15e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—ovarian cancer	4.15e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—ovarian cancer	4.15e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	4.14e-06	2.17e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	4.13e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	4.1e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—ovarian cancer	4.09e-06	2.15e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	4.09e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—ovarian cancer	4.09e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—ovarian cancer	4.08e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—ovarian cancer	4.08e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—ovarian cancer	4.06e-06	2.13e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—ovarian cancer	4.06e-06	2.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—ovarian cancer	4.05e-06	2.13e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—ovarian cancer	4.05e-06	2.13e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—ovarian cancer	4.04e-06	2.12e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—ovarian cancer	4.02e-06	2.11e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	4.02e-06	2.11e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	4.02e-06	2.11e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.01e-06	2.11e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—ovarian cancer	3.99e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—ovarian cancer	3.98e-06	2.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	3.97e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.97e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—ovarian cancer	3.96e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—ovarian cancer	3.96e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	3.96e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—ovarian cancer	3.95e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—ovarian cancer	3.95e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	3.95e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	3.95e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—ovarian cancer	3.95e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—ovarian cancer	3.95e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	3.94e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	3.94e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—ovarian cancer	3.92e-06	2.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—ovarian cancer	3.92e-06	2.06e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—ovarian cancer	3.92e-06	2.06e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	3.9e-06	2.05e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	3.9e-06	2.05e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	3.89e-06	2.04e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	3.89e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	3.83e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	3.83e-06	2.01e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	3.8e-06	2e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—ovarian cancer	3.79e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—ovarian cancer	3.79e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—ovarian cancer	3.78e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—ovarian cancer	3.77e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAV1—ovarian cancer	3.75e-06	1.97e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	3.74e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	3.73e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	3.72e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	3.68e-06	1.93e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—ovarian cancer	3.68e-06	1.93e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	3.67e-06	1.93e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	3.67e-06	1.93e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	3.66e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—ovarian cancer	3.66e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—ovarian cancer	3.66e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—ovarian cancer	3.63e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—ovarian cancer	3.62e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—ovarian cancer	3.62e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—ovarian cancer	3.61e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	3.54e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	3.54e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.52e-06	1.85e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	3.51e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—ovarian cancer	3.51e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—ovarian cancer	3.51e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—ovarian cancer	3.5e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—ovarian cancer	3.5e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—ovarian cancer	3.5e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—ovarian cancer	3.5e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—ovarian cancer	3.5e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—ovarian cancer	3.5e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	3.46e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—ovarian cancer	3.46e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.44e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.44e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—ovarian cancer	3.43e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.43e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—ovarian cancer	3.42e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.42e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	3.42e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	3.38e-06	1.78e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	3.37e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—ovarian cancer	3.37e-06	1.77e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	3.36e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	3.35e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	3.35e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—ovarian cancer	3.34e-06	1.75e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—ovarian cancer	3.34e-06	1.75e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—ovarian cancer	3.32e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—ovarian cancer	3.31e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—ovarian cancer	3.31e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—ovarian cancer	3.31e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	3.3e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—ovarian cancer	3.3e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—ovarian cancer	3.27e-06	1.72e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	3.26e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—ovarian cancer	3.26e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—ovarian cancer	3.26e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—ovarian cancer	3.23e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—ovarian cancer	3.23e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	3.19e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	3.19e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—ovarian cancer	3.19e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—ovarian cancer	3.19e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.17e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	3.16e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	3.13e-06	1.64e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	3.12e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—ovarian cancer	3.11e-06	1.64e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	3.1e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.04e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—ovarian cancer	3.03e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—ovarian cancer	3.01e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—ovarian cancer	3.01e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.01e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—ovarian cancer	3e-06	1.57e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	2.99e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.98e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—ovarian cancer	2.87e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	2.86e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—ovarian cancer	2.81e-06	1.48e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—ovarian cancer	2.81e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	2.8e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—ovarian cancer	2.79e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	2.79e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—ovarian cancer	2.77e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	2.77e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	2.77e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	2.76e-06	1.45e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	2.76e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—ovarian cancer	2.7e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—ovarian cancer	2.7e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—ovarian cancer	2.68e-06	1.41e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—ovarian cancer	2.68e-06	1.41e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.66e-06	1.4e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—ovarian cancer	2.65e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.62e-06	1.38e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.59e-06	1.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—ovarian cancer	2.56e-06	1.34e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—ovarian cancer	2.56e-06	1.34e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—ovarian cancer	2.53e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—ovarian cancer	2.45e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—ovarian cancer	2.45e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.44e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—ovarian cancer	2.43e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.42e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—ovarian cancer	2.34e-06	1.23e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.26e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—ovarian cancer	2.26e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—ovarian cancer	2.26e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—ovarian cancer	2.17e-06	1.14e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—ovarian cancer	2.12e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—ovarian cancer	2e-06	1.05e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.98e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.6e-06	8.39e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.3e-06	6.85e-06	CbGpPWpGaD
